Mountain bike film to benefit Ride to Conquer Cancer

Mountain bike film to benefit Ride to Conquer Cancer

What’s better than watching two epic bike films with a bunch of bike-enthusiasts, while helping to raise money for the Ride to Conquer Cancer? Not much.

July 7 and 8, Trail Bicycles is hosting two films — Anthill Films’ Not Bad and the premiere of the highly anticipated sequel Not2Bad — at the Frelones building, 2781 Dunsmuir Avenue, in Cumberland.

Advance tickets are available for $10 at Trail Bicycles, 1999 Lake Trail Road in Courtenay, and at the door depending on availability. All proceeds of the event will benefit the Ride to Conquer Cancer, a 200-km. bike ride from Vancouver to Seattle that raises money for the B.C. Cancer Foundation.

“We’re all really looking forward to these films,” says Jeff Beeston, owner of Trail Bicycles. “The original Not2Bad film featured 30 days of bicycle tomfoolery in New Zealand; the sequel will see the same cast partaking in even more bicycle tomfoolery in Spain. It’s been called sensational, romantic, decent, and the best movie of all time. If you like bikes or hate cancer, pick up a ticket and judge for yourself.”

On Thursday, July 7, doors open at 5:30pm for an all-ages screening at 6 p.m. There will also be a 19+ screening at 8:00, with beverages from Cumberland Brewing Company and doors opening at 7:30. There will be an additional 19+ screening at 8 p.m. on Friday, July 8, and another all-ages show may be added if the first sells out.

Tickets are on sale now at Trail Bicycles, 1999 Lake Trail Road in Courtenay. For more information, call 250-334-2456 or email shop@trailbicycles.ca.

Comments

comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Disclaimer: We are committed to maintaining a lively but civil forum for discussion and as such personal attacks, offensive language and irrelevant comments may be removed. Comments that appear on this site are not the opinion of Currently Cumberland, but only of the comment writer. Currently Cumberland may publish these comments within the paper and on digital platforms.